MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

NCT07045571 · clinicaltrials.gov ↗
RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yingbin Liu, MD, PhD, FACS

Collaborators